Shilpa Medicare gets European authority nod for Tadalafil drug
Shilpa Medicare informed that it has received marketing authorization from Portugal, Europe, for Tadalafil Orodispersible Films, 20 mg.
JD Supra1d
FDA Issues Draft Guidance on AI-Enabled Medical Devices
The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.
Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the ...
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
Mr. Ainsworth brings over two decades of industry and market access experience to TonixU.S. Food and Drug Administration (FDA) recently assigned ...